Related Experiment Video
Updated: Jun 13, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
PKB/AKT phosphorylation of the transcription factor Twist-1 at Ser42 inhibits p53 activity in response to DNA damage
A Vichalkovski1, E Gresko, D Hess
1Friedrich Miescher Institute for Biomedical Research, Maulbeerstrasse 66, Basel, Switzerland.
Abstract:
Protein kinase B (PKB/Akt) is ubiquitously expressed in cells. Phosphorylation of its multiple targets in response to various stimuli, including growth factors or cytokines, promotes cell survival and inhibits apoptosis. PKB is upregulated in many different cancers and a significant amount of the enzyme is present in its activated form. Here we show that PKB phosphorylates one of the anti-apoptotic proteins--transcription factor Twist-1 at Ser42. Cells expressing Twist-1 displayed inefficient p53 upregulation in response to DNA damage induced by gamma-irradiation or the genotoxic drug adriamycin. This influenced the activation of p53 target genes such as p21(Waf1) and Bax and led to aberrant cell-cycle regulation and the inhibition of apoptosis. The impaired induction of these p53 effector molecules is likely to be mediated by PKB-dependent phosphorylation of Twist-1 because, unlike the wild-type mutant, the Twist-1 S42A mutant did not confer cell resistance to DNA damage. Moreover, phosphorylation of Twist-1 at Ser42 was shown in vivo in various human cancer tissues, suggesting that this post-translational modification ensures functional activation of Twist-1 after promotion of survival during carcinogenesis.
Insights
Protein kinase B (PKB/Akt) promotes cancer cell survival by phosphorylating Twist-1, inhibiting p53
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Protein kinase B (PKB/Akt) is crucial for cell survival and is often upregulated in cancers.
- PKB/Akt regulates various cellular processes through phosphorylation of target proteins.
- The anti-apoptotic protein Twist-1 plays a role in cancer progression.
Purpose of the Study:
- To investigate the role of PKB/Akt in regulating the anti-apoptotic protein Twist-1.
- To determine the functional consequences of PKB/Akt-mediated phosphorylation of Twist-1.
- To explore the implications of this interaction in cancer development.
Main Methods:
- In vitro phosphorylation assays to identify PKB/Akt targets.
- Cellular studies using wild-type and mutant Twist-1.
- DNA damage induction using gamma-irradiation and adriamycin.
- Analysis of p53, p21(Waf1), and Bax expression.
- In vivo studies in human cancer tissues.
Main Results:
- PKB/Akt directly phosphorylates the anti-apoptotic protein Twist-1 at Serine 42.
- Phosphorylation of Twist-1 by PKB/Akt impairs p53 upregulation following DNA damage.
- This leads to reduced activation of p53 target genes, aberrant cell-cycle regulation, and inhibition of apoptosis.
- A Twist-1 S42A mutant failed to confer resistance to DNA damage, confirming PKB/Akt-dependent phosphorylation's role.
- Phosphorylation of Twist-1 at Ser42 was observed in human cancer tissues.
Conclusions:
- PKB/Akt-mediated phosphorylation of Twist-1 at Ser42 is a key mechanism for promoting cancer cell survival.
- This post-translational modification inhibits the p53 tumor suppressor pathway, contributing to carcinogenesis.
- Targeting the PKB/Akt-Twist-1 interaction may offer therapeutic strategies for cancer treatment.
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Negative Regulator Molecules
Inhibition of Cdk Activity
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

